How does AUPH's 2024 earnings performance compare to past years?

Aurinia Pharmaceuticals (AUPH) demonstrated significant improvements in its 2024 earnings performance compared to past years, showcasing robust growth in revenue and a turnaround in net income. 1. **Revenue Growth**: AUPH's revenue for 2024 was $235.13 million. This compares favorably to the previous year's revenue of $175.51 million, indicating a 33.6% increase. Similarly, the revenue for 2023 was $134.03 million, showing a 34.8% increase from 2022's revenue of $50.12 million. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2021 Q1|-94.27348449791762|-5.0379E7|185| |AUPH|AUPH.O|Aurinia|2021 Q2|-77.10216998191682|-4.701E7|185| |AUPH|AUPH.O|Aurinia|2021 Q3|-19.285544742463802|-5.0255E7|185| |AUPH|AUPH.O|Aurinia|2021 Q4|-312.7074560317067|-3.3322E7|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2024 Q1|58.98267572311684|-1.0749E7|185| |AUPH|AUPH.O|Aurinia|2024 Q2|106.28263139575355|722000|185| |AUPH|AUPH.O|Aurinia|2024 Q3|206.7152524726705|1.435E7|185| |AUPH|AUPH.O|Aurinia|2024 Q4|105.31720930232558|1429000|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2024 Q1|46.19140341189805|5.0303E7|185| |AUPH|AUPH.O|Aurinia|2024 Q2|37.831975707331175|5.7192E7|185| |AUPH|AUPH.O|Aurinia|2024 Q3|24.31624323580666|6.7771E7|185| |AUPH|AUPH.O|Aurinia|2024 Q4|32.75751191928152|5.9867E7|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2023 Q1|30.35875631145363|-2.6206E7|185| |AUPH|AUPH.O|Aurinia|2023 Q2|67.64184147543291|-1.1492E7|185| |AUPH|AUPH.O|Aurinia|2023 Q3|-49.593948158860826|-1.3447E7|185| |AUPH|AUPH.O|Aurinia|2023 Q4|-3.1828303770252626|-2.6875E7|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2023 Q1|59.11676300578035|3.4409E7|185| |AUPH|AUPH.O|Aurinia|2023 Q2|47.18881912667163|4.1494E7|185| |AUPH|AUPH.O|Aurinia|2023 Q3|-2.2660858029007334|5.4515E7|185| |AUPH|AUPH.O|Aurinia|2023 Q4|58.589766133286446|4.5095E7|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2022 Q1|25.306179161952404|-3.763E7|185| |AUPH|AUPH.O|Aurinia|2022 Q2|24.452244203360987|-3.5515E7|185| |AUPH|AUPH.O|Aurinia|2022 Q3|82.11322256491891|-8989000|185| |AUPH|AUPH.O|Aurinia|2022 Q4|21.83542404417502|-2.6046E7|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2022 Q1|2265.9737417943106|2.1625E7|185| |AUPH|AUPH.O|Aurinia|2022 Q2|325.8459214501511|2.8191E7|185| |AUPH|AUPH.O|Aurinia|2022 Q3|280.30272039271836|5.5779E7|185| |AUPH|AUPH.O|Aurinia|2022 Q4|21.496325414459065|2.8435E7|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2020 Q1|-108.6578693273254|-2.5932E7|185| |AUPH|AUPH.O|Aurinia|2020 Q2|-66.93289730205647|-2.6544E7|185| |AUPH|AUPH.O|Aurinia|2020 Q3||-4.213E7|185| |AUPH|AUPH.O|Aurinia|2020 Q4||-8074000|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |AUPH|AUPH.O|Aurinia|2020 Q1|0|30000|185| |AUPH|AUPH.O|Aurinia|2020 Q2|0|29000|185| |AUPH|AUPH.O|Aurinia|2020 Q3||29000|185| |AUPH|AUPH.O|Aurinia|2020 Q4||5.003E7|185| 2. **Net Income Turnaround**: AUPH's net income for 2024 was $5.75 million, a stark improvement from the net loss of $78.02 million in 2023. This turnaround is even more notable considering the company's net loss of $108.18 million in 2022 and a much larger loss of $180.97 million in 2021. 3. **Profit Margin Improvement**: The profit margin for 2024 was 2.45%, up from a loss in 2023. This indicates a significant improvement in profitability. The profit margin was also positive in 2022, albeit at a lower rate, with a net income of $5.75 million compared to a loss in 2021. 4. **Consistent Quarterly Performance**: AUPH's quarterly financials for 2024 show consistent growth. The company beat earnings expectations in Q2 with revenue of $57.2 million and net income of $722,000. In Q3, revenue increased to $67.8 million with a net income of $14.4 million. The first quarter of 2024 also saw revenue of $50.30 million, which was 6.01% above analyst estimates. In conclusion, AUPH's 2024 earnings performance reflects substantial growth and profitability compared to the previous years, with strong revenue increases and a notable recovery from net losses to net income.